HSP90AA1 and Parkinson disease: Various HSP90 inhibitors such as SNX-0723 reduced the α-synuclein toxicity in PD via induction of the HSP70 level in a PD rat model, indicating it as a promising candidate to protect against neurodegeneration [137,138].